Vision Loss Night

2

Review clinical trials related to Vision Loss Night. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

OPI-NXYDLD-303 Safety and Efficacy of Phentolamine Ophthalmic Solution in Keratorefractive Surgery Participants With Decreased Mesopic Visual Acuity

The goal of this clinical trial is to learn if Phentolamine Ophthalmic Solution works to treat adults that have had keratorefractive surgery and have decreased visual acuity under mesopic conditions. It will also learn about the safety of Phentolamine Ophthalmic Solution. The main questions it aims to answer are: Researchers will compare Phentolamine Ophthalmic Solution to a placebo (a look-alike substance that contains no drug) to see if Phentolamine Ophthalmic Solution works to improve vision in low light conditions. Participants will: Take Phentolamine Ophthalmic Solution or a placebo drop every day for 2 weeks Visit the clinic once every week for 2 weeks for checkups and tests Keep a diary of when they instill the study medication each evening

Participants needed: 580
Trial details
Phase: Phase 3Age: 18+Biological sex: AllType: InterventionalSponsor: Ocuphire Pharma, Inc.Updated: Sep 8, 2026Locations: 20
Eligibility criteria

Males or females ≥ 18 years of age [+7]

Prior unresolved dry eye diagnosis, taking prescription medication for dry eye (... [+22]

Status: Recruiting

Stem Cell Ophthalmology Treatment Study II

This study will evaluate the use of autologous bone marrow derived stem cells (BMSC) for the treatment of retinal and optic nerve damage or disease.

Participants needed: 500
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: MD Stem CellsUpdated: Jun 29, 2026Locations: 4
Eligibility criteria

Have objective, documented damage to the retina or optic nerve unlikely to impro... [+7]

Patients who are not capable of an adequate ophthalmologic examination or evalua... [+3]